Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01778582 · ClinicalTrials.gov registry record

Perspective-taking, and Examining the Clinical Trial Informed Consent Process

A clinical trial of Emotions and Informed Consent, sponsored by National Cancer Institute (NCI).

Completed
Registry status
200
Enrollment target
1
Study location

NCT01778582: Completed study of Emotions and Informed Consent, sponsored by National Cancer Institute (NCI).

NCT01778582 is a study of Emotions and Informed Consent that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 200 participants, above the 175-participant average among 16 other Emotions trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01778582, a study of Emotions and Informed Consent, has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

Background: \- Very few people with cancer participate in clinical trials. Some are uncertain about the treatment, or are afraid of being treated like a guinea pig. They may also feel that they have inadequate information about the trial. One possible way of encouraging people to sign up for clinical trials is to improve the informed consent process. Researchers want to understand how people read and understand informed consent documents. Objectives: \- To study perspective taking, and to study how people understand the information and enrollment process for a clinical trial. Eligibility: \- Healthy volunteers at least 18 years of age. Design: * This study will require one study visit. * Participants will watch one of four movie clips. They will be asked to respond to the film by looking at it from the main character s perspective. They will then answer questions about how the clips made them feel. * Participants will read a sample cancer clinical trial consent form on a computer. The computer will record their eye movements while they read the text. They will then be asked whether they remember the information in the consent form, and whether they would participate in the trial. * No treatment will be provided as part of this study.

Study Locations (1)

Maryland

  • National Cancer Institute (NCI), 9000 Rockville Pike - Bethesda

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2012-11-15
Est. Completion 2013-10-08
National Cancer Institute (NCI)

3,257 total trials

What the finished NCT01778582 record still lists

NCT01778582 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 175-participant average among 16 other Emotions trials with a reported enrollment target (14% higher).

The record links to 2 conditions, with Emotions appearing as the primary indexed condition, and to 0 interventions.

NCT01778582 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT01778582 about?

NCT01778582 is a clinical study titled "Perspective-taking, and Examining the Clinical Trial Informed Consent Process". Background: \- Very few people with cancer participate in clinical trials. Some are uncertain about the treatment, or are afraid of being treated like a guinea pig. They may also feel that they have inadequate information about the trial. One possible way of encouraging people to sign up for clinic...

What is the current status of trial NCT01778582?

This trial is currently completed. The enrollment target is 200 participants. The study started on 2012-11-15. Estimated completion is 2013-10-08.

What conditions does trial NCT01778582 study?

This clinical trial studies the following conditions: Emotions, Informed Consent.

Who is sponsoring clinical trial NCT01778582?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01778582 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Emotions

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01778582's enrollment target sits among peer trials

200 5th of 16 higher than 11 of 16 other Emotions trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Emotions trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01778582, the US trial registry maintained by the National Library of Medicine. NCT01778582 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.